Pay in 4 interest-free payments of $5.26 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
& Kanwar, Y
Presented for research literature review only Landry J et al
Yang XD, Li WJ, Liu JY (2005) Isolation and characterization of a novel PHGPx gene in Raphanus sativus
J Med Genet
Legitimate Research Directions: Some peptides DO have potential and are being properly studied: Thymosin Alpha-1: Immune support (approved in 35+ countries, trials in US) BPC-157: IF proper human trials ever happen LL-37: Antimicrobial applications Others: Many peptides have theoretical promise But ONLY if studied properly: Randomized controlled trials Safety studies FDA approval process Medical supervision The Problem: Most "wellness peptides" will NEVER go through this process because: They can't be patented (no profit incentive) Companies would rather sell in gray market Proper trials cost $100M+ If trials show they DON'T work, the market disappears So we're stuck in limbo: promising animal data, zero human data, aggressive marketing
How do I reconstitute 1000 mg of nicotinamide adenine dinucleotide (NAD) for intravenous infusion in a sterile, aseptic manner?
US$ 25.80
US$ 28.56
US$ 22.75
US$ 29.45
US$ 21.89
